New York City, NY -- (SBWIRE) -- 10/29/2013 -- StockMarketIntel.com issues a special report on the following stocks: Nestle SA Reg Shs. Ser. B Spons (ADR) (OTCMKTS:NSRGY), Wells Fargo & Co (NYSE:WFC), VIVUS, Inc. (NASDAQ:VVUS), Oclaro, Inc. (NASDAQ:OCLR)
Nestle SA Reg Shs. Ser. B Spons (ADR) (OTCMKTS:NSRGY) declined -0.34%, trading on 381,855 shares, to end the trade at $73.38. The stock changed hands in a range of $73.05 to $73.54, bringing its market capitalization to about $237.44 billion. If we look at its trading history of the past 52 weeks, the share price suffered a low of $61.50 and was moved to the maximum level of $73.90. Nestle SA is a Switzerland-based holding company of the Nestle Group (the Group) and is principally engaged in the development and production of food and beverage. The Group manages its Food and Beverages business through three geographic zones (Zone Europe, Zone Americas and Zone Asia, Oceania and Africa) and globally for Nestle Waters, Nestle Nutrition and Other Food and Beverages (Others).
Why Should Investors Buy NSRGY After the Recent Fall? Just Go Here and Find Out
Wells Fargo & Co (NYSE:WFC) declined -0.07%, to complete the trading session at $42.83, with a total volume of 12.67 million shares. The stock, on average, trades on a volume of 19.75 million shares. It floated in a range of $42.57 to $42.99 during the last trading session, with a beta value of 1.59. Its market capitalization now moved to about $225.87 billion. In the past 52 weeks, the share price has not declined below $31.25 and above $44.78. Wells Fargo & Company is a bank holding company. The Company is a diversified financial services company. It has three operating segments: Community Banking, Wholesale Banking and Wealth, Brokerage and Retirement. The Company provides retail, commercial and corporate banking services through banking stores and offices, the Internet and other distribution channels to individuals, businesses and institutions in all 50 states, the District of Columbia and in other countries.
Will WFC Get Buyers Even After The Recent Rally? Find Out Here
VIVUS, Inc. (NASDAQ:VVUS) added 2.13% and was in a range of $9.33-$9.75 before closing at $9.59. The share price hit its 52-week low of $9.11 and $18.33 was the best price. The stock completed the day with a total volume of 1.26 million shares, versus an average volume of 2.78 million shares. VIVUS, Inc. is a biopharmaceutical company. It commercializes and develops therapies to address unmet needs in obesity, sleep apnea, diabetes and sexual health. Its drug, Qsymia (phentermine and topiramate extended-release) was approved by the the United States Food and Drug Administration (FDA) for the treatment of obesity as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index (BMI) of 30 or greater (obese), or 27 or greater (overweight) in the presence of at least one weight-related comorbidity, such as hypertension, type 2 diabetes mellitus or high cholesterol (dyslipidemia). Qsymia incorporates low doses of active ingredients from two previously approved drugs, phentermine and topiramate.
Will VVUS Continue To Move Higher? Find Out Here
Oclaro, Inc. (NASDAQ:OCLR) declined -5.12%, bringing its market capitalization around $180.64 million. The total number of shares that changed hands during the session was 1.11 million shares, as compared to average trading volume of 1.47million shares. The share price, after opening at $2.02, made a high of $2.07 and hovered above $1.90 to end the day at $1.95. Oclaro, Inc., is a provider of optical communications and laser components, modules and subsystems for a range of markets, including telecommunications (telecom), industrial, scientific, consumer electronics and medical. The Company’s product offerings include tunable laser, lithium niobate external modulators, pump laser chips, thin film filters, and amplifiers. The Company is a supplier of optical network technology to telecom equipment companies worldwide.
Will OCLR Bounce Back After yesterday’s Sharp Sell off? Find Out Here
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)